The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-27
DOI
10.1186/s13195-022-01117-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection and quantification of Aβ−3–40 (APP669‐711) in cerebrospinal fluid
- (2022) Hans‐Wolfgang Klafki et al. JOURNAL OF NEUROCHEMISTRY
- Performance of plasma phosphorylated tau 181 and 217 in the community
- (2022) Michelle M. Mielke et al. NATURE MEDICINE
- Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
- (2022) Thomas K. Karikari et al. Nature Reviews Neurology
- Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light
- (2022) Suzanne E. Schindler et al. NEUROLOGY
- Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment
- (2022) Yan Hu et al. JAMA Network Open
- Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity
- (2022) Stephen Zicha et al. Alzheimers & Dementia
- An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
- (2022) Sebastian Palmqvist et al. Alzheimers & Dementia
- Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy
- (2022) Kazuto Yamashita et al. Alzheimers Research & Therapy
- Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance
- (2022) Alexa Pichet Binette et al. Alzheimers & Dementia
- Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
- (2022) Shorena Janelidze et al. BRAIN
- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- The search for a convenient procedure to detect one of the earliest signs of Alzheimer's disease: A systematic review of the prediction of brain amyloid status
- (2021) Miriam T. Ashford et al. Alzheimers & Dementia
- Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
- (2021) Henrik Zetterberg et al. Molecular Neurodegeneration
- A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
- (2021) Tim West et al. Molecular Neurodegeneration
- Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
- (2021) Claudia Cicognola et al. Alzheimers Research & Therapy
- Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau
- (2021) Shorena Janelidze et al. Alzheimers & Dementia
- Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids
- (2021) Magdalena Korecka et al. JOURNAL OF NEUROCHEMISTRY
- Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advances
- (2021) Joyce R. Chong et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The informed road map to prevention of Alzheimer Disease: A call to arms
- (2021) Eric McDade et al. Molecular Neurodegeneration
- Biomarkers for neurodegenerative diseases
- (2021) Oskar Hansson NATURE MEDICINE
- Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
- (2021) Sebastian Palmqvist et al. NATURE MEDICINE
- Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
- (2021) Nicholas C. Cullen et al. Nature Communications
- Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
- (2021) Shorena Janelidze et al. JAMA Neurology
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
- (2021) Charlotte E Teunissen et al. LANCET NEUROLOGY
- Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques
- (2021) Yan Li et al. NEUROLOGY
- Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer’s Disease
- (2020) Patrick Oeckl et al. JOURNAL OF PROTEOME RESEARCH
- Empowering Clinical Diagnostics with Mass Spectrometry
- (2020) Shibdas Banerjee ACS Omega
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. NATURE MEDICINE
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Head‐to‐head comparison of amplified plasmonic exosome Aβ42 platform and single‐molecule array immunoassay in a memory clinic cohort
- (2020) Tomotaka Tanaka et al. EUROPEAN JOURNAL OF NEUROLOGY
- Incidence of inborn errors of metabolism detected by tandem mass spectrometry in China: A census of over seven million newborns between 2016 and 2017
- (2020) Kui Deng et al. JOURNAL OF MEDICAL SCREENING
- Renal function is associated with blood neurofilament light chain level in older adults
- (2020) Shoshin Akamine et al. Scientific Reports
- Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis
- (2020) Steffi De Meyer et al. Alzheimers Research & Therapy
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
- (2020) Shorena Janelidze et al. JAMA Neurology
- Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease
- (2019) Andrea Vergallo et al. Alzheimers & Dementia
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
- (2019) Virginia Pérez-Grijalba et al. Alzheimers Research & Therapy
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes
- (2018) Inge M.W. Verberk et al. ANNALS OF NEUROLOGY
- Evaluation of Plasma Aβ as Predictor of Alzheimer's Disease in Older Individuals Without Dementia: A Population-Based Study
- (2018) Oskar Hansson et al. JOURNAL OF ALZHEIMERS DISEASE
- Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
- (2017) Jong-Chan Park et al. Alzheimers Research & Therapy
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study
- (2015) Vincent Chouraki et al. Alzheimers & Dementia
- Novel plasma biomarker surrogating cerebral amyloid deposition
- (2014) Naoki KANEKO et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
- (2011) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Hypoxia Due to Cardiac Arrest Induces a Time-Dependent Increase in Serum Amyloid β Levels in Humans
- (2011) Henrik Zetterberg et al. PLoS One
- Receiver Operating Characteristic Curve in Diagnostic Test Assessment
- (2010) Jayawant N. Mandrekar Journal of Thoracic Oncology
- Evolution of Aβ42 and Aβ40 levels and Aβ42/Aβ40 ratio in plasma during progression of Alzheimer’s disease: A multicenter assessment
- (2009) K. Blennow et al. Journal of Nutrition Health & Aging
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started